$KEQU
KEWAUNEE SCIENTIFIC CORP /DE/ Stock $kequ

$kequ Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-K Financial Statement

#000005552921000013 Filed on July 15, 2021

Income Statement

Concept	2020 Q2	2020 Q1	2020
Revenue	$34.26M	$34.23M	$147.5M
YoY Change	-1.41%	5.72%	0.68%
Cost Of Revenue	$29.37M	$28.95M	$124.1M
YoY Change	-1.81%	6.65%	2.38%
Gross Profit	$4.887M	$5.278M	$23.43M
YoY Change	0.93%	0.92%	-7.47%
Gross Profit Margin	14.27%	15.42%	15.88%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development			$1.816M
YoY Change			17.16%
% of Gross Profit			7.75%
Depreciation & Amortization	$720.0K	$640.0K	$2.654M
YoY Change	9.09%	-1.54%	3.23%
% of Gross Profit	14.73%	12.13%	11.33%
Operating Expenses	$5.900M	$7.350M	$25.77M
YoY Change	-4.38%	40.48%	11.05%
Operating Profit	-$1.013M	-$2.072M	-$2.345M
YoY Change	-23.72%	103500.0%	-211.03%
Interest Expense	-$40.00K	$150.0K	$493.0K
YoY Change	-63.64%	97.37%	34.33%
% of Operating Profit
Other Income/Expense, Net	-$70.00K	-$30.00K	$0.00
YoY Change	-36.36%	-115.79%	-100.0%
Pretax Income	-$1.120M	-$2.251M	-$2.866M
YoY Change	-27.74%	-6531.43%	-234.3%
Income Tax	-$60.00K	-$350.0K	$1.758M
% Of Pretax Income
Net Earnings	-$1.062M	-$1.918M	-$4.687M
YoY Change	-16.38%	8618.18%	-406.54%
Net Earnings / Revenue	-3.1%	-5.6%	-3.18%
Basic Earnings Per Share	-$0.39	-$0.70	-$1.70
Diluted Earnings Per Share	-$0.39	-$0.70	-$1.70
COMMON SHARES
Basic Shares Outstanding		2.750M shares	2.750M shares
Diluted Shares Outstanding		2.750M shares	2.750M shares

Balance Sheet

Concept	2020 Q2	2020 Q1	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.370M	$3.550M	$4.370M
YoY Change	-58.97%	-67.04%	-58.97%
Cash & Equivalents	$4.365M	$3.554M	$4.370M
Short-Term Investments
Other Short-Term Assets	$6.470M	$7.010M	$6.470M
YoY Change	52.24%	59.68%	52.24%
Inventory	$15.33M	$15.25M	$15.33M
Prepaid Expenses
Receivables	$28.06M	$27.41M	$28.06M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$54.23M	$53.22M	$54.23M
YoY Change	-17.02%	-10.94%	-17.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.27M	$15.91M	$25.58M
YoY Change	-1.15%	4.62%	55.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.778M	$3.332M	$4.110M
YoY Change	5.68%	13.8%	-23.89%
Total Long-Term Assets	$29.70M	$31.14M	$29.70M
YoY Change	35.82%	57.23%	35.86%
TOTAL ASSETS
Total Short-Term Assets	$54.23M	$53.22M	$54.23M
Total Long-Term Assets	$29.70M	$31.14M	$29.70M
Total Assets	$83.93M	$84.36M	$83.93M
YoY Change	-3.78%	6.03%	-3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.11M	$11.66M	$13.11M
YoY Change	-13.67%	5.0%	-13.69%
Accrued Expenses	$6.700M	$8.000M	$6.700M
YoY Change	343.71%	64.95%	27.62%
Deferred Revenue	$2.508M	$1.800M
YoY Change	56.85%	24.14%
Short-Term Debt	$4.719M	$4.020M	$4.720M
YoY Change	-50.38%	-21.48%	-50.37%
Long-Term Debt Due	$0.00	$0.00	$20.00K
YoY Change	-100.0%	-100.0%	-98.31%
Total Short-Term Liabilities	$27.06M	$25.50M	$27.06M
YoY Change	-17.33%	7.55%	-17.32%
LONG-TERM LIABILITIES
Long-Term Debt	$110.0K	$120.0K	$110.0K
YoY Change	-52.17%	-77.36%	-52.17%
Other Long-Term Liabilities	$569.0K	$1.031M	$17.65M
YoY Change	-16.32%	-83.75%	169.05%
Total Long-Term Liabilities	$569.0K	$1.031M	$17.76M
YoY Change	-16.32%	-83.75%	161.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.06M	$25.50M	$27.06M
Total Long-Term Liabilities	$569.0K	$1.031M	$17.76M
Total Liabilities	$45.23M	$41.41M	$45.51M
YoY Change	14.44%	37.81%	13.43%
SHAREHOLDERS EQUITY
Retained Earnings	$37.82M	$38.88M
YoY Change	-13.16%	-14.25%
Common Stock	$10.25M	$10.24M
YoY Change	2.37%	0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$53.00K	$53.00K
YoY Change	0.0%	0.0%
Treasury Stock Shares	3.000K shares	3.000K shares
Shareholders Equity	$38.42M	$42.65M	$38.42M
YoY Change
Total Liabilities & Shareholders Equity	$83.93M	$84.36M	$83.93M
YoY Change	-3.78%	6.03%	-3.77%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2020
OPERATING ACTIVITIES
Net Income	-$1.062M	-$1.918M	-$4.687M
YoY Change	-16.38%	8618.18%	-406.54%
Depreciation, Depletion And Amortization	$720.0K	$640.0K	$2.654M
YoY Change	9.09%	-1.54%	3.23%
Cash From Operating Activities	-$450.0K	$110.0K	$4.161M
YoY Change	-77.94%	-95.07%	67.11%
INVESTING ACTIVITIES
Capital Expenditures	-$1.100M	-$650.0K	-$2.470M
YoY Change	-42.71%	-33.67%	-41.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.100M	-$650.0K	-$2.465M
YoY Change	-42.71%	-33.67%	-41.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$1.282M
YoY Change			8.92%
Cash From Financing Activities	700.0K	-2.990M	-$7.458M
YoY Change	-80.34%	647.5%	-419.54%
NET CHANGE
Cash From Operating Activities	-450.0K	110.0K	$4.161M
Cash From Investing Activities	-1.100M	-650.0K	-$2.465M
Cash From Financing Activities	700.0K	-2.990M	-$7.458M
Net Change In Cash	-850.0K	-3.530M	-$5.941M
YoY Change	112.5%	-515.29%	-3100.51%
FREE CASH FLOW
Cash From Operating Activities	-$450.0K	$110.0K	$4.161M
Capital Expenditures	-$1.100M	-$650.0K	-$2.470M
Free Cash Flow	$650.0K	$760.0K	$6.631M
YoY Change	-641.67%	-76.32%	-1.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000055529
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-04-30
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	0-5286
CY2021	dei	Entity Registrant Name EntityRegistrantName	KEWAUNEE SCIENTIFIC CORPORATION
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-0715562
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2700 West Front Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Statesville
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28677-2927
CY2021	dei	City Area Code CityAreaCode	704
CY2021	dei	Local Phone Number LocalPhoneNumber	873-7202
CY2021	dei	Security12b Title Security12bTitle	Common Stock $2.50 par value
CY2021	dei	Trading Symbol TradingSymbol	KEQU
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Public Float EntityPublicFloat	20723171	USD
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2770503	shares
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147469000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147540000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123476000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	124113000	USD
CY2021	us-gaap	Gross Profit GrossProfit	23993000	USD
CY2020	us-gaap	Gross Profit GrossProfit	23427000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	25309000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	25772000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1316000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-2345000	USD
CY2021	us-gaap	Pension Expense PensionExpense	1153000	USD
CY2020	us-gaap	Pension Expense PensionExpense	454000	USD
CY2021	us-gaap	Other Income OtherIncome	241000	USD
CY2020	us-gaap	Other Income OtherIncome	426000	USD
CY2021	us-gaap	Interest Expense InterestExpense	389000	USD
CY2020	us-gaap	Interest Expense InterestExpense	493000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2617000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2866000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	990000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1758000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-3607000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4624000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	65000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	63000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4687000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2760000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2750000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2760000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2750000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-3607000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4624000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-444000	USD
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	6044000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-2748000	USD
CY2021	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	0	USD
CY2020	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	1000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2414000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7815000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	65000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	63000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2349000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7878000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	47100000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4687000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3191000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.38
CY2020	us-gaap	Dividends Cash DividendsCash	1044000	USD
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2300	shares
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	237000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	38415000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6021000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	477000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	41241000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5206000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	525000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	850000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	636000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	606000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34095000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28062000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	16517000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	15330000	USD
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	955000	USD
CY2020Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2717000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3159000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2907000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	60457000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	54231000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15982000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16272000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9279000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9312000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	336000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3666000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3778000	USD
CY2021Q2	us-gaap	Assets Assets	89384000	USD
CY2020Q2	us-gaap	Assets Assets	83929000	USD
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	6828000	USD
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	4719000	USD
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	21000	USD
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1348000	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1282000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	16780000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13114000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4726000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4159000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3123000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2508000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1355000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1259000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	34181000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	27060000	USD
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	91000	USD
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	113000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7860000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7780000	USD
CY2021Q2	kequ	Accrued Employee Benefit Plan Costs AccruedEmployeeBenefitPlanCosts	4652000	USD
CY2020Q2	kequ	Accrued Employee Benefit Plan Costs AccruedEmployeeBenefitPlanCosts	9303000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	307000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	401000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	806000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	569000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	47897000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	45226000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2766000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2754000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2763000	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2751000	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	6915000	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	6885000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3807000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3360000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34149000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	37821000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3577000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9598000	USD
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	3000	shares
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	3000	shares
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	53000	USD
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	53000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	41241000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	38415000	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	246000	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	288000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41487000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38703000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89384000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83929000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-3607000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4624000	USD
CY2021	us-gaap	Depreciation Depreciation	2687000	USD
CY2020	us-gaap	Depreciation Depreciation	2654000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	53000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	364000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	634000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	251000	USD
CY2021	kequ	Deferred Income Tax Expense Benefit Net Of Rate Adjustment DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment	1662000	USD
CY2020	kequ	Deferred Income Tax Expense Benefit Net Of Rate Adjustment DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment	1895000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6087000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4833000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1188000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1876000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1762000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2717000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4567000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2016000	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	615000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	909000	USD
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-186000	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	736000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	912000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4161000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2397000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2465000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2397000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2465000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1044000	USD
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	108000	USD
CY2020	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	324000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	62205000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	58721000	USD
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	60096000	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	63515000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1282000	USD
CY2021	kequ	Net Proceeds From Exercise Of Stock Options Including Tax Benefit NetProceedsFromExerciseOfStockOptionsIncludingTaxBenefit	0	USD
CY2020	kequ	Net Proceeds From Exercise Of Stock Options Including Tax Benefit NetProceedsFromExerciseOfStockOptionsIncludingTaxBenefit	-14000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1982000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7458000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-179000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	516000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5941000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5215000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11156000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5731000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5215000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	65000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	513000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1800000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	188000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company reclassified certain amounts in the consolidated balance sheet for the period ended April 30, 2020 and the consolidated statements of cash flows for the year ended April 30, 2020 to conform to the current period presentation. There was no impact to the consolidated statements of operations or statements of stockholders' equity for fiscal year 2020.</span>
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5206000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	525000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	850000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5731000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5215000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	606000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	361000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	53000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	364000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	23000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	119000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	636000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	606000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6929000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6131000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	58804000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57859000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42822000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41587000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15982000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16272000	USD
CY2021	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	The Company reviews the carrying value of property, plant and equipment for impairment whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, inventory valuation, self-insurance reserves, and pension liabilities.</span>
CY2021Q2	us-gaap	Derivative Assets DerivativeAssets	2757000	USD
CY2021Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	3169000	USD
CY2020Q2	us-gaap	Derivative Assets DerivativeAssets	2572000	USD
CY2020Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2899000	USD
CY2020Q2	kequ	Number Of Nonqualified Compensation Plans NumberOfNonqualifiedCompensationPlans	2	compensation_plan
CY2021Q2	kequ	Number Of Nonqualified Compensation Plans NumberOfNonqualifiedCompensationPlans	2	compensation_plan
CY2021Q2	us-gaap	Construction Contractor Receivable Retainage ConstructionContractorReceivableRetainage	1668000	USD
CY2020Q2	us-gaap	Construction Contractor Receivable Retainage ConstructionContractorReceivableRetainage	1928000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Credit Concentration The Company performs credit evaluations of its customers.
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1406000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1816000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	174000	USD
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2760000	shares
CY2020	us-gaap	Advertising Expense AdvertisingExpense	332000	USD
CY2021	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company records derivatives on the consolidated balance sheets at fair value and establishes criteria for designation and effectiveness of hedging relationships. The nature of the Company's business activities involves the management of various financial and market risks, including those related to changes in interest rates. The Company does not enter into derivative instruments for speculative purposes. In May 2013, the Company entered into an interest rate swap agreement whereby the interest rate payable by the Company on $2,600,000 of outstanding long-term debt was effectively converted to a fixed interest rate of 4.37% for the period beginning August 1, 2017 and ending May 1, 2020. In May 2013, the Company entered into an interest rate swap agreement whereby the interest rate payable by the Company on $1,218,000 of outstanding long-term debt was effectively converted to a fixed interest rate of 3.07% for the period beginning November 3, 2014 and ending May 1, 2020. The Company entered into these interest rate swap arrangements to mitigate future interest rate risk associated with its long-term debt and has designated these as cash flow hedges. The Company terminated the interest rate swap arrangements in conjunction with the payoff of the outstanding long-term debt in September 2019. (See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4a1243076c3c482c91a2ed6f4f94e820_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt and Other Credit Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.)</span>
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	166880	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	121311	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2760000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2750000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2750000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147469000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147540000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6929000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6131000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3123000	USD
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2508000	USD
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2988000	USD
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2455000	USD
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1832000	USD
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1921000	USD
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11697000	USD
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10954000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	16517000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	15330000	USD
CY2013Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	20000000	USD
CY2019Q4	kequ	Debt Instrument Asset Based Lending Maximum Borrowing Capacity DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity	20000000	USD
CY2020Q1	kequ	Debt Instrument Asset Based Lending Maximum Borrowing Capacity DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity	15000000	USD
CY2021Q2	kequ	Minimum Ebitda Covenant Requirement For Year End Fy21 MinimumEBITDACovenantRequirementForYearEndFY21	1000000	USD
CY2021Q2	kequ	Minimum Ebitda Covenant Requirement Revision Ebitda Increase By Scheduled One Time Non Recurring Addbacks Threshold Amount MinimumEBITDACovenantRequirementRevisionEBITDAIncreaseByScheduledOneTimeNonRecurringAddbacksThresholdAmount	250000	USD
CY2021Q2	kequ	Minimum Ebitda Covenant Requirement Revision Ebitda Increase By Solely Fourth Quarter Period One Time Non Recurring Addbacks Threshold Amount MinimumEBITDACovenantRequirementRevisionEBITDAIncreaseBySolelyFourthQuarterPeriodOneTimeNonRecurringAddbacksThresholdAmount	600000	USD
CY2021Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	7500000	USD
CY2020Q1	kequ	Coronavirus Aid Relief And Economic Security Act Net Operating Loss Carryback Period CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod	P5Y
CY2021	kequ	Income Tax Expense Gilti IncomeTaxExpenseGILTI	0	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-396000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2289000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	49000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1136000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1567000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	748000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-673000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	449000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1233000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-135000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	438000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-72000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	760000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	242000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2431000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	990000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1758000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-470000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-567000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-129000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-115000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	415000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	477000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	17000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3000	USD
CY2021	kequ	Effective Income Tax Rate Reconciliation Effect Of Change In Enacted Tax Rate On Deferred Tax Assets Amount EffectiveIncomeTaxRateReconciliationEffectOfChangeInEnactedTaxRateOnDeferredTaxAssetsAmount	0	USD
CY2020	kequ	Effective Income Tax Rate Reconciliation Effect Of Change In Enacted Tax Rate On Deferred Tax Assets Amount EffectiveIncomeTaxRateReconciliationEffectOfChangeInEnactedTaxRateOnDeferredTaxAssetsAmount	-47000	USD
CY2021	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	226000	USD
CY2020	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	1964000	USD
CY2021	kequ	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	-118000	USD
CY2020	kequ	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	939000	USD
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-42000	USD
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	38000	USD
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-67000	USD
CY2020	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	5000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	196000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	990000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1538000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1707000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	80000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1758000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	296000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	402000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	154000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	150000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1283000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	890000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	978000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	532000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	638000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	638000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	15000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	58000	USD
CY2021	kequ	Share Based Compensation Deferred Tax Expense Benefit ShareBasedCompensationDeferredTaxExpenseBenefit	3000	USD
CY2020	kequ	Share Based Compensation Deferred Tax Expense Benefit ShareBasedCompensationDeferredTaxExpenseBenefit	14000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3700	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	15.97
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	1196000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	2616000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	69000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	102000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	572000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	457000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	568000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	506000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5754000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6293000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1596000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1545000	USD
CY2021Q2	kequ	Deferred Tax Liabilities Prepaid Pension Cost DeferredTaxLiabilitiesPrepaidPensionCost	847000	USD
CY2020Q2	kequ	Deferred Tax Liabilities Prepaid Pension Cost DeferredTaxLiabilitiesPrepaidPensionCost	1111000	USD
CY2021Q2	kequ	Deferred Tax Liabilities Apb23 Assertion DeferredTaxLiabilitiesAPB23Assertion	765000	USD
CY2020Q2	kequ	Deferred Tax Liabilities Apb23 Assertion DeferredTaxLiabilitiesAPB23Assertion	786000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14050	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.78
CY2021Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	122000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	304000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3330000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3746000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2731000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2612000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	307000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	65000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	307000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	65000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5754000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2731000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	808000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	638000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1136000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	482000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	88000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.45
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	104350	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.28
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2300	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.98
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	84300	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.56
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	88000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.45
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	84300	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.56
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	83400	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.16
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6407000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-444000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	1000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	-3592000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-844000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9598000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-23000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	6044000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3577000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9279000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9312000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1799000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1526000	USD
CY2021	kequ	Lessee Remaining Lease Term LesseeRemainingLeaseTerm	P8Y
CY2021	kequ	Lessee Optionto Extend Term LesseeOptiontoExtendTerm	P5Y
CY2021	kequ	Lessee Optionto Terminate Term LesseeOptiontoTerminateTerm	P1Y
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	2854000	USD
CY2021	kequ	Operating Lease Short Term Expense OperatingLeaseShortTermExpense	1055000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	2441000	USD
CY2020	kequ	Operating Lease Short Term Expense OperatingLeaseShortTermExpense	915000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y7M6D
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.100
CY2020Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2020Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.100
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2018000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	32000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1833000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	32000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1475000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	32000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1431000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	32000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1220000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	13000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2864000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10841000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	141000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1633000	USD
CY2021Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	28000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	9208000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	113000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	22942000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	23720000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	23720000	USD
CY2019Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	21394000	USD
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	723000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	832000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-97000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	2769000	USD
CY2021	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	1404000	USD
CY2020	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	1275000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	22942000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	23720000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	17316000	USD
CY2019Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	19035000	USD
CY2021	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	5517000	USD
CY2020	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-444000	USD
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	30000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2021	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	1404000	USD
CY2020	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	1275000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	21459000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	17316000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-1483000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-6404000	USD
CY2021Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	1483000	USD
CY2020Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	6404000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	5089000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	11133000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	1196000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	2616000	USD
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1153000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	3893000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	8517000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0320
CY2020Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0310
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0320
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0310
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0775
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0775
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	723000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	832000	USD
CY2021	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1284000	USD
CY2020	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1421000	USD
CY2021	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	-1714000	USD
CY2020	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	-1043000	USD
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	454000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Amortization Next Fiscal Year DefinedBenefitPlanExpectedAmortizationNextFiscalYear	560000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	0	USD
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	30000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	1540000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	1580000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	1620000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	1590000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	1570000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	7390000	USD
CY2021	kequ	Defined Benefit Plan Percentage Changes In Discount Rate DefinedBenefitPlanPercentageChangesInDiscountRate	0.01
CY2020	kequ	Defined Benefit Plan Percentage Changes In Discount Rate DefinedBenefitPlanPercentageChangesInDiscountRate	0.01
CY2021	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	165000	USD
CY2020	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	183000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	21459000	USD
CY2021Q2	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2020Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	17316000	USD
CY2020Q2	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2021	kequ	Defined Contribution Plan Age Limit Of Employees To Be Eligible For Catch Up Contributions DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions	P21Y
CY2021	kequ	Defined Contribution Plan Eligibility Minimum Service Period DefinedContributionPlanEligibilityMinimumServicePeriod	P3M
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2021	kequ	Defined Contribution Plan Employer Matching Contributions Amount DefinedContributionPlanEmployerMatchingContributionsAmount	997000	USD
CY2020	kequ	Defined Contribution Plan Employer Matching Contributions Amount DefinedContributionPlanEmployerMatchingContributionsAmount	974000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147469000	USD
CY2021	us-gaap	Depreciation Depreciation	2687000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2617000	USD
CY2021	kequ	Revenues Including Intersegment Markup RevenuesIncludingIntersegmentMarkup	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	990000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	65000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672000	USD
CY2021Q2	us-gaap	Assets Assets	89384000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2397000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	147540000	USD
CY2020	kequ	Revenues Including Intersegment Markup RevenuesIncludingIntersegmentMarkup	0	USD
CY2020	us-gaap	Depreciation Depreciation	2654000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2866000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1758000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	63000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4687000	USD
CY2020Q2	us-gaap	Assets Assets	83929000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2465000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36423000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39000000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33339000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38707000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	5881000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	6395000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	5654000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	6063000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-608000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-165000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	95000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2929000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10000	USD
CY2020Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	46000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-598000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-180000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	81000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2975000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2019Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.19
CY2020Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39336000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39722000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34225000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34257000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	6946000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	6316000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	5278000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	4887000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	496000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	-2161000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1901000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-1058000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	25000	USD
CY2019Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	471000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-2178000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1918000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1062000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2019Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.19
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2020Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0

Files In Submission

Name	View Source	Status
0000055529-21-000013-index-headers.html	Edgar Link	pending
0000055529-21-000013-index.html	Edgar Link	pending
0000055529-21-000013.txt	Edgar Link	pending
0000055529-21-000013-xbrl.zip	Edgar Link	pending
a11thamendment.htm	Edgar Link	pending
a11thamendment001.jpg	Edgar Link	pending
a11thamendment002.jpg	Edgar Link	pending
a11thamendment003.jpg	Edgar Link	pending
a11thamendment004.jpg	Edgar Link	pending
a11thamendment005.jpg	Edgar Link	pending
a11thamendment006.jpg	Edgar Link	pending
a11thamendment007.jpg	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit231001.jpg	Edgar Link	pending
exhibit232.htm	Edgar Link	pending
exhibit232001.jpg	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit311001.jpg	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit312001.jpg	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit321001.jpg	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
exhibit322001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kequ-20210430.htm	Edgar Link	pending
kequ-20210430.xsd	Edgar Link	pending
kequ-20210430_cal.xml	Edgar Link	unprocessable
kequ-20210430_def.xml	Edgar Link	unprocessable
kequ-20210430_htm.xml	Edgar Link	completed
kequ-20210430_lab.xml	Edgar Link	unprocessable
kequ-20210430_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KEQU
KEWAUNEE SCIENTIFIC CORP /DE/ Stock $kequ

2020 Q2 Form 10-K Financial Statement

#000005552921000013 Filed on July 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KEQU KEWAUNEE SCIENTIFIC CORP /DE/ Stock $kequ

2020 Q2 Form 10-K Financial Statement

#000005552921000013 Filed on July 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KEQU
KEWAUNEE SCIENTIFIC CORP /DE/ Stock $kequ